Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone implant for post-vitrectomy macular edema
NCT02995746Terminated
- Sponsor
- Wills Eye Hospital
- Start
- Jan 2016
- Primary completion
- Sep 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of dexamethasone in macular edema, sponsored by Wills Eye Hospital. Primary endpoint: Mean central macular thickness at 6 months. Started Jan 2016; status: terminated.
02
Drugs
dexamethasone
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT02995746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02995746.